GlassScriptPhysician profile
James M Parker
NPI 1407888555
$5,257.36
in general payments reported to CMS, 2019-2025
28 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $92.20 · 2021: $487 · 2022: $313 · 2023: $471 · 2024: $988 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,728 · Travel and Lodging: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,727.74 |
| Travel and Lodging | $1,268.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,724.71 | 2023-2025 | Aveir, Jot Dx, Cardiomems |
| Medtronic, INC. | $760.39 | 2021-2025 | Linq II, Aurora Ev-Icd Mri Surescan, Selectsecure |
| Abiomed | $723.91 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $255.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $219.63 | 2023-2025 | Verquvo |
| Philips North America LLC | $159.89 | 2024-2025 | Igt Devices Systems Undivided, (6571) Eagle Eye, (Ck4) Mcot |
| Novartis Pharmaceuticals Corporation | $145.33 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $132.24 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $127.69 | 2019-2025 | Emblem Mri S-Icd, Cds - Mct/Cem Monitoring |
| Angiodynamics, INC. | $119.55 | 2024 | Auryon Laser System 100-120 Vac |
| E.R. Squibb & Sons, L.L.C. | $113.83 | 2024-2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.18 | 2023-2025 | Jardiance |
| Davol INC. | $81.67 | 2025 | Arista |
| Kestra Medical Technology Services, INC. | $73.30 | 2023-2025 | Assure Wcd |
| Novo Nordisk INC | $71.41 | 2024-2025 | Wegovy, Ozempic |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $69.48 | 2022-2023 | |
| Pfizer INC. | $48.06 | 2022-2025 | |
| Biosense Webster, INC. | $46.03 | 2025 | Na, Nuvision Ice Catheter |
| Astrazeneca Pharmaceuticals LP | $43.06 | 2020-2024 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $34.28 | 2024 | Uptravi |
| Amgen INC. | $33.36 | 2024 | Repatha |
| Terumo Medical Corporation | $32.48 | 2023 | Glidewire, Glidesheath Slender, Angio-Seal |
| Innovation Technologies INC | $30.80 | 2024 | Irrisept |
| Acist Medical Systems, INC. | $26.34 | 2025 | |
| Chiesi USA, INC. | $20.49 | 2024 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $19.44 | 2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $19.32 | 2024 | |
| Sanofi-Aventis U.S. LLC | $13.55 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.